NCT00170157View on ClinicalTrials.gov

Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

April 30, 2011

Study Completion Date

June 30, 2013

Conditions
Prostate AdenocarcinomaProstate CarcinomaRecurrent Prostate CarcinomaStage III Prostate CancerStage IV Prostate Cancer
Interventions
DRUG

Bicalutamide

Given orally

DRUG

Flutamide

Given orally

DRUG

Goserelin Acetate

Given SC

DRUG

Ipilimumab

Given IV

DRUG

Leuprolide Acetate

Given IM

OTHER

Pharmacological Study

Correlative study

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER